EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Ethnopharmacological Insights Into Pausinystalia Genus: Botany, Phytochemistry, and Pharmacological Potential

Ahequeli Gemingnuer, Yinan Wang, Xuemei Zhang, Hailing Wang, Xin Meng

Chemistry & Biodiversity · 2026-11 · 23 (11)

DOI: 10.1002/cbdv.71937 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 20.11.2026. Verfasst von Ahequeli Gemingnuer und 4 weiteren Autor:innen. Die Arbeit nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Pausinystalia genus (Rubiaceae) comprises woody plants mainly distributed in tropical Africa and has a long history of traditional medicinal use, particularly as aphrodisiacs and for treating fatigue, fever, leprosy, and respiratory infections. At least 52 compounds have been identified or reported from the genus, including 37 indole alkaloids, phenolic compounds, flavonoids, and fatty acids. These constituents and derived extracts or fractions exhibit diverse biological activities, including effects on sexual function, antimicrobial, antioxidant, hypoglycemic, anti‐inflammatory, analgesic, cardioprotective, insecticidal, and cytotoxic activities. However, evidence remains uneven across species and pharmacological endpoints, with research focusing largely on Pausinystalia yohimbe , Pausinystalia macroceras , and their alkaloid constituents. Variations in plant materials, extraction procedures, chemical composition, doses, models, and outcome measures limit cross‐study comparisons and extrapolation. This review critically synthesizes the botanical characteristics, ethnomedicinal uses, phytochemistry, pharmacological properties, and toxicological profiles of Pausinystalia , emphasizing evidence quality, species differences, methodological limitations, and research gaps. Future research priorities, including chemical standardization, pharmacokinetic and biotransformation studies, mechanistic validation, safety evaluation, quality control, clinical investigation, and sustainable utilization, are discussed to support the reproducible, evidence‐based, and clinically relevant development of Pausinystalia ‐derived preparations.

Zitieren

APA

Gemingnuer, A., Wang, Y., Zhang, X., Wang, H., & Meng, X. (2026). Ethnopharmacological Insights Into Pausinystalia Genus: Botany, Phytochemistry, and Pharmacological Potential. Chemistry & Biodiversity, 23(11). https://doi.org/10.1002/cbdv.71937

Vancouver

Gemingnuer A, Wang Y, Zhang X, Wang H, Meng X. Ethnopharmacological Insights Into Pausinystalia Genus: Botany, Phytochemistry, and Pharmacological Potential. Chemistry & Biodiversity. 2026;23(11). doi:10.1002/cbdv.71937

BibTeX
@article{Gemingnuer2026,
  author = {Gemingnuer, Ahequeli and Wang, Yinan and Zhang, Xuemei and Wang, Hailing and Meng, Xin},
  title = {Ethnopharmacological Insights Into Pausinystalia Genus: Botany, Phytochemistry, and Pharmacological Potential},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  volume = {23},
  number = {11},
  doi = {10.1002/cbdv.71937}
}
Kostenlos starten →